Although our study revealed a consistent reduction in mtDNA content, prior studies revealed variable correlations with clinical features such as age, tumor grade, hormone receptor status, and metastasis, suggesting that further studies are needed to clarify these inconsistencies. The gene discussed is NR4A1; the disease is neoplasm.